Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial
In patients with chronic pancreatitis and insulin-treated diabetes, CGM increased time in range and reduced time above and below range. These findings highlight the potential of CGM in improving glycaemic control.
Authors
- Line Davidsen (ORCID: https://orcid.org/0000-0002-1120-8144)
- Morten Hasselstrøm Jensen (ORCID: https://orcid.org/0000-0002-6649-8644)
- Søren Schou Olesen (ORCID: https://orcid.org/0000-0003-3916-3168)
- Asbjørn Mohr Drewes (ORCID: https://orcid.org/0000-0001-7465-964X)
- Peter Vestergaard (ORCID: https://orcid.org/0000-0002-9046-2967)
- Filip K. Knop (ORCID: https://orcid.org/0000-0002-2495-5034)
- Peter Stæhr
- Simon Lebech Cichosz (ORCID: https://orcid.org/0000-0002-3484-7571)
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Novo Nordisk (Denmark) (DK)
- Aalborg University Hospital (DK)
- Gentofte Hospital (DK)
- North Denmark Region (DK)
- Mech-Sense (DK)
- Aalborg University (DK)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1111/dom.16356
- Citations
- 2
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Dexcom